Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Delayed Quote USD

Milestone Pharmaceuticals Inc. (MIST)

Compare
0.7600
-0.0401
(-5.01%)
At close: April 1 at 4:00:00 PM EDT
0.7599
-0.00
(-0.01%)
After hours: April 1 at 7:59:51 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
1,000
5,000
15,000
Operating Expense
42,102
42,102
62,098
64,642
58,073
Operating Income
-42,102
-42,102
-61,098
-59,642
-43,073
Net Non Operating Interest Income Expense
583
583
1,413
1,254
220
Pretax Income
-41,519
-41,519
-59,685
-58,388
-42,853
Net Income Common Stockholders
-41,519
-41,519
-59,685
-58,388
-42,853
Diluted NI Available to Com Stockholders
-41,519
-41,519
-59,685
-58,388
-42,853
Basic EPS
-0.67
--
-1.39
-1.38
-1.02
Diluted EPS
-0.67
--
-1.39
-1.38
-1.02
Basic Average Shares
62,210.7020
--
42,955.7790
42,450.3160
41,833.8610
Diluted Average Shares
62,210.7020
--
42,955.7790
42,450.3160
41,833.8610
Total Operating Income as Reported
-42,102
-42,102
-61,098
-59,642
-43,073
Total Expenses
42,102
42,102
62,098
64,642
58,073
Net Income from Continuing & Discontinued Operation
-41,519
-41,519
-59,685
-58,388
-42,853
Normalized Income
-41,519
-41,519
-59,685
-58,388
-42,853
Interest Income
4,164
4,164
3,967
1,254
220
Interest Expense
3,581
3,581
2,554
--
--
Net Interest Income
583
583
1,413
1,254
220
EBIT
-37,938
-37,938
-57,131
-58,388
-43,073
EBITDA
-37,833
-37,833
-57,039
-58,299
-42,980
Reconciled Depreciation
105
105
92
89
93
Net Income from Continuing Operation Net Minority Interest
-41,519
-41,519
-59,685
-58,388
-42,853
Normalized EBITDA
-37,833
-37,833
-57,039
-58,299
-42,980
12/31/2021 - 5/9/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

THTX Theratechnologies Inc.
1.4000
0.00%
 
DRMA Dermata Therapeutics, Inc.
0.9997
-7.44%
 
OCEA Ocean Biomedical, Inc.
0.0549
+1.67%
 
LXRX Lexicon Pharmaceuticals, Inc.
0.4641
+0.72%
 
LPTX Leap Therapeutics, Inc.
0.2913
-4.52%
 
DBVT DBV Technologies S.A.
6.46
-5.28%
 
OSRH OSR Holdings, Inc.
1.7200
-8.51%
 
RNAZ TransCode Therapeutics, Inc.
0.5409
+9.27%
 
PRTG Portage Biotech Inc.
8.26
-10.70%
 
MURA Mural Oncology plc
1.2400
-1.59%